Combined Technologies Approach could Ease Drug Development

News

Combined Technologies Approach could Ease Drug Development

03 Mar, 2020

Published over 6 years ago. See the latest and most current information on News.

A formal partnership that combines Arctoris’ automated drug discovery platform and Molecule’s distributed IP ownership platform aims to reduce some of the problems facing drug discovery development initiatives across both industry and academia.

"Drug discovery researchers worldwide face enormous challenges posed by a widespread lack of reproducibility and the limited availability of standardised, structured, high quality data. By partnering with Molecule, we intend to make drug discovery and development more democratic, collaborative and efficient in the interest of bringing higher-quality therapeutics to patients faster through the combination of robotics, AI and a distributed research platform,” said Martin-Immanuel Bittner, MD DPhil, Co-Founder and CEO of Arctoris.

Arctoris recently opened its fully automated research facility based in Oxford (UK) where robotics perform a range of the most frequent drug discovery assays for researchers worldwide.

“We aim to create an open source ecosystem for collaborative drug development thereby distributing the cost, risk and ownership of drug development by offering fractional ownership in pharmaceutical IP in exchange for preclinical or clinical development work, as well as funding. Through this partnership with Arctoris, our joint aim is to accelerate innovation and advances in drug discovery and development, more rapidly bringing drugs to market and enhancing patient therapies,” said Tyler Golato, Co-Founder & Chief Scientist at Molecule.

The two companies are will combining their technologies to create a modular pipeline for distributed therapeutics development in which they will involve universities, patient advocacy groups, pharmaceutical and biotechnological companies, as well as investors. Shares in intellectual property or direct funding will be provided to stakeholders that participate in the development of therapeutics.

Latest News

LMUK 51.7 Nov 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Vehicle-based methane detection system passes German suitability test
Explore more Arrow
Pollution Solutions Online
Large-scale liquefied biogas bunkering to become possible in the Port of Gothenburg in 2027
Explore more Arrow
Petro Online
Hydrogen sulphide deaths expose the gaps in gas detection during non-routine work
Explore more Arrow
Chromatography Today
High-load peptide purification
Explore more Arrow